Breast cancer patient benefits from modified immunotherapy

Researchers designed a novel approach to immunotherapy that led to the complete regression of breast cancer in a patient for whom all other treatments failed.

https://www.nih.gov/news-events/nih-research-matters/breast-cancer-patient-benefits-modified-immunotherapy

Jason E. Barkeloo
Chairman & Founder, Open Therapeutics